Role of arginine vasopressin V1a and V2 receptors for secondary brain damage after experimental traumatic brain injury

Ähnliche Einträge

• Glibenclamide reduces secondary brain damage after experimental traumatic brain injury
  von: Zweckberger, Klaus, et al.
  Veröffentlicht: (2014)
• The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice
  von: Walter, Johannes, et al.
  Veröffentlicht: (2023)
• Interleukin-1 receptor 1 deletion in focal and diffuse experimental traumatic brain injury in mice
  von: Chung, Joon Yong, et al.
  Veröffentlicht: (2019)
• Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis
  von: Beez, Thomas, et al.
  Veröffentlicht: (2017)
• Traumatic brain injury: progress and challenges in prevention, clinical care, and research
  von: Maas, Andrew I., et al.
  Veröffentlicht: (2022)